+966 568813716 [email protected]

Post Graduate

Home / E-Lessons / Medical Students / Archive by category "Post Graduate"
24
Apr
2026
AI’s Impact on OCD: Clinical Presentation & Pharmacotherapy
Posted On April 24, 2026  By [email protected]  And has No Comment

HOW AI IS RESHAPING OCD SYMPTOM PRESENTATION A. New AI-Driven Obsessional Themes OCD latches onto whatever is most threatening or uncertain in a person’s environment. AI has created entirely new content domains for obsessions: AI-Related OCD Theme Obsessional Fear Compulsive Response AI Surveillance OCD “AI is […]

Read More

24
Apr
2026
AI’s Impact on Psychiatric Symptom Presentation and Management Policy
Posted On April 24, 2026  By [email protected]  And has No Comment

TRULY NEW ERA! 1. Shifting Symptom Landscapes New AI-mediated symptom patterns: 2. Diagnostic Challenges Challenge Clinical Implication AI-shaped symptom language Patients describe symptoms using AI terminology, making phenomenological assessment harder Blunted help-seeking AI chatbots provide “good enough” support, delaying formal diagnosis by months to years Confabulation […]

Read More

19
Feb
2026
الكلوزابين: لا داعي للقلق و الخوف منه
Posted On February 19, 2026  By [email protected]  And has No Comment

الكلوزابين: علاج فعال وآمن تحت إشراف طبي دقيق عزيزي المريض، الكلوزابين هو دواء مميز وفعال جداً في علاج الفصام والاضطرابات الذهانية، خاصة في الحالات التي لم تستجب للأدوية الأخرى. يعتبر هذا الدواء من أقوى العلاجات المتاحة وأكثرها نجاحاً في السيطرة على الأعراض الذهانية مثل الهلاوس والأوهام […]

Read More

13
Feb
2026
BLS – detailed for exam
Posted On February 13, 2026  By [email protected]  And has No Comment

Read More

05
Feb
2026
Can Mirtazapine treat ADHD? What is the Connection?
Posted On February 5, 2026  By [email protected]  And has No Comment

From sleepless nights to scattered thoughts, the quest for ADHD relief takes an unexpected turn down the path of an antidepressant that might just be the game-changer patients have been waiting for. As individuals with Attention Deficit Hyperactivity Disorder (ADHD) continue to search for effective treatments, […]

Read More

27
Jul
2025
Gabapentin and Dementia Risk
Posted On July 27, 2025  By [email protected]  And has No Comment

Based on the Medscape article about gabapentin and dementia risk, sum up. Gabapentin and Dementia Risk: New Research Findings Study Overview • Anticonvulsant gabapentin linked to increased cognitive decline risk • Led by Nafis Eghrari, Case Western Reserve University • Published in Regional Anesthesia & Pain […]

Read More

27
Jul
2025
Heavy cannabis use and long-term memory
Posted On July 27, 2025  By [email protected]  And has No Comment

Based on the article from Psychiatrist.com, here’s a summary of the key findings about heavy cannabis use and long-term memory: Study Overview and Motivation Researchers led by Joshua Gowin from the University of Colorado School of Medicine conducted the largest study to date examining cannabis effects […]

Read More


17
Jun
2025
Eye Signs in different Psychiatric Disorders
Posted On June 17, 2025  By [email protected]  And has No Comment

Eye signs and symptoms provide valuable diagnostic and monitoring information across various psychiatric disorders. Here’s an in-depth analysis of these ocular manifestations: Schizophrenia Smooth Pursuit Eye Movement (SPEM) Abnormalities: Deficits in smooth pursuit and an excess of ‘jerky’ eye movements were one of the earliest reported […]

Read More

23
May
2025
Sulpiride and AmiSulpiride is there a a clinical difference ?
Posted On May 23, 2025  By [email protected]  And has No Comment

Sulpiride and amisulpride are both benzamide antipsychotics primarily used in the treatment of schizophrenia and, in some cases, depression or anxiety disorders. Despite their similarities, they have important differences in structure, pharmacodynamics, and clinical applications. 🔬 Core Molecular Differences Property Sulpiride Amisulpride Chemical Class Substituted benzamide […]

Read More


Page 1 of 18